|
Immunizations
> Vaccine
Preventable Disease Statistics
RSV
& Rapid Antigen Flu Results
2006-2007
Last
Updated
Monday, April 20, 2009 3:38 PM
Influenza activity in the Pacific Northwest is increasing, especially among younger age groups, however the increase is not significantly different from what the region experiences each year at this time. School absenteeism is also increasing, but is below levels usually seen at this time of the flu season. Preliminary review of surveillance for influenza-like-illnesses (ILI) in emergency rooms in the region shows an increase in ILI visits, as expected in late January and early February of each influenza season. Ninety-seven percent of the influenza isolates received at the PHL and typed here or at the CDC have been influenza type A strains covered by this year's vaccine and we are beginning to see some influenza type B, typical for this time of the year. Nationally, flu activity is also increasing with no unusual or atypical strains of influenza identified. Nationally, there have been 7 pediatric deaths reported, including a reported death of a young child due to influenza in King County. Death due to influenza in a child less than 19 years of age is notifiable as a rare disease of public health significance. Healthcare providers should report pediatric deaths confirmed or suspected to be due to influenza to your local health department. In turn, local health jurisdictions are asked to notify DOH of these deaths. It's not too late to give or get influenza vaccine, which will still provide protection for the end of this year's season. Additional information on influenza can be found at http://www.doh.wa.gov/FluNews/default.htm The 2006-07 ACIP recommendations for influenza vaccination and antiviral use can be found at: http://www.cdc.gov/flu/professionals/vaccination/
MedWatch - The FDA Safety Information and Adverse Event Reporting Program
Roche notified healthcare professionals of a correction to a Dear Healthcare professional letter issued on November 13, 2006. The original letter referenced changes to the PRECAUTIONS Section of prescribing information for Tamiflu about post marketing reports of self-injury and delirium with the use of Tamiflu in patients with influenza. The prescribing information that accompanied the letter contained an incorrect dosing chart for the Standard Dosage of Tamiflu Oral Suspension for prophylaxis of influenza in pediatric patients. The chart incorrectly specified twice daily instead of once daily dosing under "Recommended Dose" for 10 days. Healthcare professionals should discard the incorrect version of the package insert included in the November 13 mailing and refer to the new dosing chart included in the December 26 letter.
Read the complete MedWatch Safety summary, including a link to the manufacturer's Dear Healthcare Professional Letter at: http://www.fda.gov/medwatch/safety/2007/safety07.htm#Tamiflu
DISCLAIMER:
Data below collected
from Yakima Valley Memorial
Hospital, Yakima Regional,
Toppenish Community Hospital,
and Sunnyside Community Hospital,
Prosser Memorial Hospital
(G'View Residents), PAML,
and Interpath labs. Because
we do not include private
provider testing results,
this is not an accurate representation
of the total number of cases
in our county. It provides
only a general guideline.
| |
Week
Of |
Total
RSV Tests |
+
RSV Tests |
|
+
Influenza Tests |
| 39 |
Sept 25-Oct 1 |
21 |
1 |
6 |
0 |
| 40 |
Oct 2-8 |
18 |
0 |
13 |
0 |
| 41 |
Oct 9-15 |
22 |
2 |
14 |
0 |
| 42 |
Oct 16-22 |
29 |
0 |
18 |
0 |
| 43 |
Oct 23-29 |
26 |
2 |
18 |
0 |
| 44 |
Oct 30-Nov 5 |
20 |
0 |
18 |
0 |
| 45 |
Nov 6-12 |
27 |
1 |
22 |
0 |
| 46 |
Nov 13-19 |
43 |
2 |
20 |
0 |
| 47 |
Nov 20-26 |
31 |
1 |
23 |
0 |
| 48 |
Nov 27-Dec 3 |
38 |
5 |
25 |
1 |
| 49 |
Dec 4-10 |
38 |
3 |
42 |
3 |
| 50 |
Dec 11-17 |
20 |
3 |
32 |
0 |
| 51 |
Dec 18-24 |
19 |
1 |
36 |
5 |
| 52 |
Dec 25-31 |
61 |
2 |
57 |
7 |
| 1 |
Jan 1-7 |
56 |
13 |
52 |
5 |
| 2 |
Jan 8-14 |
71 |
14 |
61 |
4 |
| 3 |
Jan 15-21 |
73 |
18 |
67 |
12 |
| 4 |
Jan 22-28 |
94 |
25 |
119 |
24 |
| 5 |
Jan 29-Feb 4 |
98 |
24 |
200 |
46 |
| 6 |
Feb 5-11 |
132 |
30 |
319 |
89 |
| 7 |
Feb 12-18 |
135 |
36 |
273 |
77 |
| 8 |
Feb 19-25 |
109 |
32 |
215 |
51 |
| 9 |
Feb 26-Mar 4 |
100 |
24 |
156 |
26 |
| 10 |
Mar 5-11 |
93 |
30 |
136 |
24 |
| 11 |
Mar 12-18 |
67 |
25 |
90 |
16 |
| 12 |
Mar 19-25 |
37 |
16 |
47 |
4 |
| 13 |
Mar 26-Apr 1 |
34 |
17 |
23 |
5 |
| 14 |
Apr 2-8 |
32 |
13 |
16 |
2 |
| 15 |
Apr 9-15 |
22 |
13 |
22 |
1 |
| 16 |
April 16-22 |
17 |
7 |
16 |
2 |
| 17 |
Apr 23-29 |
22 |
9 |
16 |
0 |
| 18 |
Apr 30-May 6 |
16 |
0 |
5 |
1 |
| 19 |
May 7-13 |
33 |
8 |
24 |
0 |
| 20 |
May 14-20 |
26 |
2 |
14 |
0 |
| 21 |
May 21-27 |
18 |
1 |
7 |
1 |
| 22 |
May 28-June 3 |
17 |
1 |
4 |
0 |
| |
Total |
1879 |
401 (21%) |
2382 |
419 (17%) |
For 2005-2006 information, please click here.
For
2004-2005 information, please
click
here.

current as of 6/6/07

current as of 6/6/07

current as of 6/6/07

current as of 6/6/07

current as of 6/6/07

current as of 6/6/07

current as of 4/27/07

current as of 4/13/07

current as of 4/13/07
RSV
& Influenza Links
Respiratory Syncytial Virus - CDC Document
MMWR Brief Report: Respiratory Syncytial Virus Activity --- United States, 2004--2005
Revised Indications for the Use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the Prevention of Respiratory Syncytial Virus Infections
Communicable Disease Epidemiology Flu Update
American
Health Care Association
American
Assocation of Homes and Services
for the Aging
CDC's
Influenza Information
Washington
State Department Flu News
Recommended
daily dosage of influenza
antiviral medications for
treatment and prophylaxis
2006-2007
Influenza Vaccination Pocket
Information Guide - Revised |